ISO 10993-3:2014 specifies strategies for risk estimation and selection of hazard identification tests, with respect to the possibility of the following potentially irreversible biological effects arising as a result of exposure to medical devices:
genotoxicity;
carcinogenicity;
reproductive and developmental toxicity.
ISO 10993-3:2014 is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, or reproductive toxicity has been established.
PROJECT
ISO/FDIS 10993-3
50.20
Proof sent to secretariat or FDIS ballot initiated: 8 weeks
Apr 16, 2026
Biological evaluation of medical devices - Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity, and developmental toxicity (ISO/FDIS 10993-3:2026)
50.20 Proof sent to secretariat or FDIS ballot initiated: 8 weeks
To view the full content, you need to register or to log in to your account by clicking on the "Log in" button